Stacey Kowal currently serves as a principal researcher in Genentech’s Health Policy and Systems Research team where her work focuses on identifying and testing new methods to assess the impact of new healthcare technologies. Her background includes both US and global work to inform health technology assessment (HTA) and reimbursement as well as design of public health interventions, drawing on disciplines of applied mathematics, economics, and international health policy. She brings more than 15 years of experience in health economics and outcomes research (HEOR), with an emphasis on using economic modeling, real world data and patient-reported outcomes to improve decision-making for governments, pharmaceutical and device manufacturers, health payers, HTA bodies and patients. Stacey’s current research aims to increase focus on equity effects in HEOR, including integration of distributional elements into healthcare decision-making. Stacey is a Udall scholar, a Truman scholar and a Marshall scholar. She holds a BS in Mathematics from Alma College, an MSc in public health from the London School of Hygiene and Tropical Medicine and an MSc in International Health Policy and Economics from the London School of Economics.
